Skip to main content

Valproinsäurebelastungstests

  • Conference paper
Book cover Valproinsäure
  • 20 Accesses

Zusammenfassung

Die Behandlung mit Valproinsäure ist bei einer großen Zahl von Epilepsiesyndromen im Kindesalter indiziert, wirksam und bei einigen für die andauernde Kontrolle epileptischer Anfälle zugunsten einer besseren Entwicklung unverzichtbar. Gerade in dieser Gruppe von Patienten, insbesondere bei den jüngeren Kindern, hat sich die schwerwiegendste Therapiekomplikation, das Leberausfallskoma als wesentlich häufiger gezeigt als bei älteren Kindern, Jugendlichen und Erwachsenen. Daher sind anhand der Erfahrungen in den Fällen von Lebertoxizität Parameter wie Ammoniak, Carnitin, Valproinsäuremetaboliten identifiziert worden, die im Rahmen von Belastungstests vor oder zu Beginn der Behandlung geprüft wurden. All diese Tests haben jedoch nicht einer wissenschaftlichen Prüfung standgehalten, und die dabei erhobenen Veränderungen stellen keine Kriterien von verläßlich prädiktivem Wert dar: Normale Befunde schließen die Möglichkeit einer Toxizität ebensowenig wie auffällige Befunde die Behandlung mit Valproinsäure begründet aus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Böhles H, Richter K, Wagner-Thiessen E, Schäfer H (1982) Decreased serum carnitine in valproate-induced Reye syndrome. Europ J Pediatr 139:185–186

    Article  Google Scholar 

  • Coulter DL (1984) Carnitine deficiency: A possible mechanism for valproate hepatotoxicity. Lancet 1:684

    Google Scholar 

  • Dreifuss FE (1989) Hepatic side effects of valproate. Fourth International Symposium on sodium valproate and epilepsy ed. D. Chadwick, Royal Society of Medical Services, London New York, pp 150–153

    Google Scholar 

  • Eadie MJ, Hooper WD, Dickinson RG (1988) Valproate-associated hepatotoxicity and its biochemical mechanisms. Medical Toxicol 3:85–106

    Article  CAS  Google Scholar 

  • Ettlin T, Scollo-Lavizarri G (1986) Hyperammoniämie unter Natriumvalproatbehandlung: klinisch relevant oder Nebenbefund? Schweiz Rundschau Med (Praxis) 29:881–885

    Google Scholar 

  • Glasgow AM, Chase HP (1975) Production of the features of Reye’s syndrome in rats with 4-pentenoic acid. Pediatric Res 9:133–138

    Article  CAS  Google Scholar 

  • Granneman GR, Wang SI, Kesterson JW, Machinist JM (1984) The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabilism. Hepatology 4:1153–1158

    Article  PubMed  CAS  Google Scholar 

  • Hulsman J (1989) Hyperammonaemia and the use of antiepileptic drugs, including valproate. Fourth International Symposium on sodium valproate and epilepsy ed. D. Chadwick, Royal Society of Medical Services, London New York, pp 163–168

    Google Scholar 

  • Kesterson JW, Granneman GR, Machinist JM (1984) The hepatotoxicity of valproic acid and metabolites in rats: I. Toxicologic, biochemical and histopathological studies. Hepatology 4:1143–1152

    Article  PubMed  CAS  Google Scholar 

  • Kochen W, Scheffner D (1980) On unsaturated metabolites of the valproic acid (VPA) in serum of children. In: Johannessen et al (eds) Antiepileptic therapy: Advances in drug monitoring. Raven, New York, pp 111–120

    Google Scholar 

  • Kochen W, Schneider A, Ritz A (1983) Abnormal metabolism of valproic acid in fatal hepatic failure. Europ J Pediatr 141:30–35

    Article  CAS  Google Scholar 

  • Kochen W, Sprunck HP, Tauscher B, Klemens M (1984) Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy. J Clin Chem Biochem 22:309–317

    CAS  Google Scholar 

  • Laub MC (1986) Nutritional influence on serum ammonia in young patients receiving sodium valproate. Epilepsia 27:55–59

    Article  PubMed  CAS  Google Scholar 

  • Laub MC, Paetzke-Brunner I, Jaeger G (1986) Serum carnitine during valproic acid therapy. Epilepsia 27:559–562

    Article  PubMed  CAS  Google Scholar 

  • Nau H, Löscher W (1984) Valproic acid and metabolites: Pharmacological and toxicological studies. Epilepsia 25 (Suppl 1): 14–22

    Article  CAS  Google Scholar 

  • Nau H, Siemes H (1989) Prospektive Multi-Center-Studie zur Bedeutung von Valproinsäure-Metaboliten in Bezug auf die Ausbildung von Lebertoxizität. Epilepsieblätter 2:49–50

    Google Scholar 

  • Oller-Daurella L, Oller, L, F-V (1991) Influence of the “lost time” of epilepsy. Eur Neurol 31:175–177

    Article  PubMed  CAS  Google Scholar 

  • Paganini M, Zaccara G, Moroni F, Campostrini R, Bendoni L, Arnetoli G, Zappoli R (1987) Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid. Eur J Clin Pharmacol 32:219–222

    Article  PubMed  CAS  Google Scholar 

  • Riva R, Zaccara G, Albani F, Galli G, Campostrini R, Paganini M, Baruzzi A (1991) Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients. Epilepsy Res 8:149–152

    Article  PubMed  CAS  Google Scholar 

  • Schäfer H, Lührs R (1984) Responsibility of the metabolite pattern for potential side effects in the rat being treated with valproic acid, 2-propylpenten-2-oic acid, and 2- propylpenten-4-oic acid. In: Levy R et al (eds) Metabolism of Antiepileptic Drugs. Raven, New York, pp 73–81

    Google Scholar 

  • Scheffner D (1986) Fatal liver failure in children on valproate. Lancet 11:511

    Article  Google Scholar 

  • Siemes H, Spohr HL, Michael T, Nau H (1988) Therapy of infantile spasms with valproate: Results of a prospective study. Epilepsia 29:553–560

    Article  PubMed  CAS  Google Scholar 

  • Sugimoto T, Woo M, Nishida N, Takeuchi T, Sakane Y, Kobayashi Y (1987) Hepatotoxicity in rat following administration of valproic acid. Epilepsia 28:142–146

    Article  PubMed  CAS  Google Scholar 

  • Sugimoto T, Araki A, Nishida N, Sakane Y, Woo M, Takeuchi T, Kobayashi Y (1987) Hepatotoxicity in rat following administration of valproic acid: Effect of L-carnitine supplementation. Epilepsia 28:373–377

    Article  PubMed  CAS  Google Scholar 

  • Tennison MB, Miles MV, Pollack GM, Thorn MD, Dupuis RE (1988) Valproate metabolites and hepatotoxicity in an epileptic population. Epilepsia 29:543–547

    Article  PubMed  CAS  Google Scholar 

  • Trauner DA (1982) Reye’s syndrome. TINS, pp 131–133

    Google Scholar 

  • Zaccara G, Campostrini R, Paganini M, Messori A, Valenza T, Arnetoli G, Zappoli R (1987) Long-term treatment with sodium valproate: Monitoring of venous ammonia concentrations and adverse effects. Ther Drug Monitoring 9:34–40

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Albani, M. (1992). Valproinsäurebelastungstests. In: Krämer, G., Laub, M.C. (eds) Valproinsäure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97843-2_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97843-2_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97844-9

  • Online ISBN: 978-3-642-97843-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics